Additional molecular biomarkers identified throughout the inflammatory microenvironment of VS that may contribute toward tumor-induced hearing loss include tumor necrosis factor alpha (TNFα), IL-6, CXCR4, and nuclear factor kappa-B (NFκB) activation (50–53). Here, TNF is linked to neoplasm.